Lv6
2410 积分 2022-04-08 加入
Targeting DNA damage response pathways in cancer
1天前
已完结
Antibody-drug conjugates for targeted cancer therapy: recent advances in potential payloads
13天前
已完结
The Evolution of Antibody‐Drug Conjugates: Toward Accurate DAR and Multi‐specificity
13天前
已完结
Ocular toxicities associated with antibody drug conjugates
18天前
已完结
Tag‐Free Enzymatic Modification for Antibody−Drug Conjugate Production
18天前
已完结
Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment
20天前
已完结
[64Cu]Cu-NOTA-Trastuzumab and [89Zr]Zr-DFO-Trastuzumab in Xenografts with Varied HER2 Expression
25天前
已完结
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
27天前
已完结
Dual-payload Antibody–drug Conjugates: Taking a Dual Shot
1个月前
已完结
Antibody Modification via Lipoic Acid Ligase A‐Mediated Site‐Specific Labeling
1个月前
已完结
皖公网安备34019202002308
